Back

New york heart association functional class does not modify the effect of an implantable cardioverter-defibrillator in nonischemic heart failure with reduced ejection fraction: a DANISH substudy

11 May 2024 (12:06 - 12:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmias in heart failure Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jawad Haider Butt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac device
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Fusion CRT pacing and LA reverse remodeling: the key for low incidence of atrial fibrillation in HF patients
Doctor C. Vacarescu (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Characterizing atrial fibrillation in patients with and without heart failure and across the ejection fraction spectrum: incidence, prevalence, and treatment strategies
Doctor V. Valente (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Heart failure detection from electrocardiogram using artificial intelligence
Doctor A. Ranjbar (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Change of natriuretic peptides over time predicts new development of atrial fibrillation in at risk population
Doctor C. Powell (Cork, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias in heart failure
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 12:06 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation/flutter may modify the long-term effect of primary prevention implantable cardioverter-defibrillators in non-ischemic HFrEF: an extended follow-up study of the DANISH trial
thumbnail
Congress Presentation
Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: pro
thumbnail
Congress Presentation
Prevention of sudden cardiac death: relevance in contemporary heart failure care

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources